Table V.
95% confidence interval | ||||
---|---|---|---|---|
Patient group | Mean | Standard error | Lower bound | Upper bound |
1 | 30.172 | 3.713 | 22.896 | 37.449 |
2 | 40.718 | 3.446 | 33.963 | 47.473 |
3 | 34.412 | 2.020 | 30.452 | 38.372 |
4 | 56.962 | 1.270 | 54.472 | 59.451 |
The patients were categorized into four groups as follows: 1, ALK FISH/ALK IHC (+/+) (n=27); 2, ALK FISH/ALK IHC (+/-) (n=12); 3, ALK FISH/ALK IHC (−/+) (n=47); 4, Both ALK FISH/ALK IHC (−/-) (n=227). ALK, anaplastic lymphoma kinase; FISH, fluorescence in situ hybridization; IHC, immunohistochemistry.